摘要
目的:探讨急性心肌梗死(AMI)院前溶栓治疗临床疗效。方法:将116例胸痛、18导联心电图显示ST段抬高的AMI且无溶栓禁忌症的患者,即时应用尿激酶(UK)150～200万u溶于生理盐水100mL中静脉滴注,30min滴完。观察用药后胸痛缓解程度、再通情况及不良反应。结果:ST段抬高的AMI患者给药越早,胸痛缓解率、再通率越高,呈线性关系,存在显著性差异,P<0.001,死亡率明显降低。结论:对ST段抬高的AMI患者,应尽早进行院前溶栓治疗以挽救生命。
Objective： To investigate clinical effect in the pre-hospital fibrinolytic treatment of patient with acute myocardial infarction（AMI）. Methods： 116 patients with chest pain and ST segment elevated in EKG and no fibrinolytic treatment contraindication were gave Urokinase 1500 000 -2000 000u by intravenous injection in the pre-hospital. Results： The recovery ratio and chest pain lease ratio were linear correlation, Recovery ratio were significantly higher with time early,P 〈 0.001. Conclusions： The patients with ST segment elevated in EKG should take the pre-hospital fibrinolytic, treatment in earliest in order to save the lives.
出处
《岭南急诊医学杂志》
2007年第2期100-101,共2页
Lingnan Journal of Emergency Medicine
关键词
急性心肌梗死
院前溶栓
尿激酶
acute myocardial infarction
pre-hospital fibrinolytic treatment
urokinase
